DK1765785T3 - Prostaglandinanaloger - Google Patents

Prostaglandinanaloger

Info

Publication number
DK1765785T3
DK1765785T3 DK05756187T DK05756187T DK1765785T3 DK 1765785 T3 DK1765785 T3 DK 1765785T3 DK 05756187 T DK05756187 T DK 05756187T DK 05756187 T DK05756187 T DK 05756187T DK 1765785 T3 DK1765785 T3 DK 1765785T3
Authority
DK
Denmark
Prior art keywords
prostaglandin analogues
compounds
prostaglandin
analogues
prodrug
Prior art date
Application number
DK05756187T
Other languages
English (en)
Inventor
David W Old
Danny T Dinh
Robert M Burk
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of DK1765785T3 publication Critical patent/DK1765785T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08Oxygen atoms
    • C07D223/10Oxygen atoms attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK05756187T 2004-07-02 2005-05-31 Prostaglandinanaloger DK1765785T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58514204P 2004-07-02 2004-07-02
US60018004P 2004-08-09 2004-08-09
PCT/US2005/019408 WO2006014206A1 (en) 2004-07-02 2005-05-31 Prostaglandin analogs

Publications (1)

Publication Number Publication Date
DK1765785T3 true DK1765785T3 (da) 2009-11-02

Family

ID=34971749

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05756187T DK1765785T3 (da) 2004-07-02 2005-05-31 Prostaglandinanaloger

Country Status (9)

Country Link
US (1) US7326698B2 (da)
EP (1) EP1765785B1 (da)
AT (1) ATE435853T1 (da)
AU (1) AU2005270229B2 (da)
CA (1) CA2571782C (da)
DE (1) DE602005015323D1 (da)
DK (1) DK1765785T3 (da)
ES (1) ES2327251T3 (da)
WO (1) WO2006014206A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7531533B2 (en) 2005-01-27 2009-05-12 Asahi Kasei Pharma Corporation 6-Membered heterocyclic compound and use thereof
WO2008136519A1 (ja) 2007-05-08 2008-11-13 National University Corporation, Hamamatsu University School Of Medicine Ep4アゴニストを含有してなる細胞傷害性t細胞の活性化剤
IT1402047B1 (it) * 2010-10-19 2013-08-28 Cross Pharma Sa Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2452536A1 (de) * 1974-11-06 1976-05-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung
US4166452A (en) * 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
ZA802765B (en) * 1979-05-23 1981-05-27 Beecham Group Ltd Novel compounds
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US5034413A (en) * 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
CA2021316C (en) * 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US5028624A (en) * 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
JPH0586034A (ja) 1991-09-27 1993-04-06 Nippon Oil & Fats Co Ltd ヒドロキシル基含有ラクタム誘導体及びその製造方法
EA005817B1 (ru) * 2000-08-01 2005-06-30 Фармасиа Корпорейшн Производные гексагидро-7-1h-азепин-2-илгексановой (или гексеновой) кислоты в качестве ингибиторов индуцибельной синтазы оксида азота
US6747037B1 (en) * 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs

Also Published As

Publication number Publication date
EP1765785A1 (en) 2007-03-28
US7326698B2 (en) 2008-02-05
CA2571782C (en) 2012-07-03
AU2005270229B2 (en) 2012-04-12
DE602005015323D1 (de) 2009-08-20
ES2327251T3 (es) 2009-10-27
EP1765785B1 (en) 2009-07-08
AU2005270229A1 (en) 2006-02-09
WO2006014206A1 (en) 2006-02-09
US20070054893A1 (en) 2007-03-08
ATE435853T1 (de) 2009-07-15
CA2571782A1 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
NO20060408L (no) Fremgangsmate for a modulere kalsium ione-frigjorings- aktivert kalsium ionekanaler
ECSP088367A (es) Derivados de bifenilo y su uso en el tratamiento de la hepatitis c
DK1814848T3 (da) 2,3,4-substitueret-cyclopentanoner som terapeutiske midler
TW200728307A (en) Novel spirochromanone derivatives
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
ATE440603T1 (de) 8-hydroxychinolinderivate
TW200714583A (en) Substituted gamma lactams as therapeutic agents
RS52874B (en) THYOPHEN ANALYSIS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200800302A1 (ru) Применение производных и аналогов тиазола при лечении рака
EA200801199A1 (ru) Ингибиторы киназы
WO2007084728A3 (en) 2-imino-benzimidazoles
DE602007014036D1 (de) 12-aryl-prostaglandin-analoga
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
MX2009003081A (es) Derivados de pirrola utiles para el tratamiento de enfermedades mediadas por citoquinas.
BRPI0617655A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
WO2008008660A3 (en) Cyclopentane derivatives as antiglaucoma agents
BRPI0716643A2 (pt) amidas terapêuticas e compostos relacionados
TNSN08369A1 (en) Benzimidazole derivatives
WO2006083841A3 (en) Therapeutic esters
DK1765785T3 (da) Prostaglandinanaloger
TW200719901A (en) Therapeutic substituted cyclopentanones